News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Daily News Patients With A-fib Still Have High Mortality Risk After Appropriate Anticoagulation Is Started Todd Neale December 05, 2016
News Daily News More A-fib, No Drop in Stroke or Death With Surgical Left Atrial Appendage Exclusion Todd Neale December 05, 2016
News Daily News Tricky Population of Patients With A-fib Undergoing PCI Tackled in New Consensus Document Todd Neale November 29, 2016
News Conference News AHA 2016 Subclinical A-fib Common in Older, Asymptomatic Patients Todd Neale November 18, 2016
News Conference News AHA 2016 Dabigatran Reversal Agent’s Safety, Efficacy Affirmed With Updated Study Results Todd Neale November 15, 2016
News Conference News AHA 2016 Rivaroxaban-Based Double or Triple Therapy Cuts Bleeding in Patients With A-fib Undergoing PCI: PIONEER AF-PCI Todd Neale November 14, 2016
Presentation TCT 2016 Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic AF Patient Who Requires PCI Presenter: David P. Faxon, C. Michael Gibson, Deepak L. Bhatt November 01, 2016
Presentation TCT 2016 General Overview and Highlights of the North American Consensus Document on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI Presenter: David P. Faxon, C. Michael Gibson, Dominick J. Angiolillo November 01, 2016
Presentation TCT 2016 European Guidelines on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI Presenter: David P. Faxon, C. Michael Gibson, Davide Capodanno November 01, 2016
News Daily News Short Bouts of Atrial Tachyarrhythmia Do Not Worsen Prognosis, Study Suggests Todd Neale October 19, 2016
News Daily News Oral Anticoagulation Use Common in PCI Patients, With Triple Therapy the Norm at Discharge Todd Neale October 18, 2016
News Daily News A-fib Screening With Smartphone-Based ECG Feasible, but Clinical Impact Unclear Todd Neale October 13, 2016
News Daily News FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm Michael O'Riordan October 11, 2016
News Daily News More NOAC Comparisons See Higher Bleeding Risk With Rivaroxaban: Is the ‘Writing on the Wall’? Shelley Wood October 07, 2016
News Daily News Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation Michael O'Riordan October 07, 2016
News Daily News Low-Dose NOACs Top Warfarin in Asian Patients in Everyday Practice, Retrospective Study Suggests Todd Neale September 26, 2016
News Conference News ESC 2016 Reversal Agent for Factor Xa Inhibitors Rapidly Reduces Anticoagulant Effects: ANNEXA-4 Todd Neale August 31, 2016
News Conference News ESC 2016 Edoxaban Shows Safety, Efficacy for A-fib Patients Undergoing Cardioversion: ENSURE-AF Todd Neale August 30, 2016
News Conference News ESC 2016 NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry Michael O'Riordan August 28, 2016